N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-4-[3,3,6,6-tetramethyl-1,8-dioxo-9-[4-[3,3,6,6-tetramethyl-1,8-dioxo-10-[4-[(5-sulfamoyl-1,3,4-thiadiazol-2-yl)carbamoyl]phenyl]-4,5,7,9-tetrahydro-2H-acridin-9-yl]phenyl]-4,5,7,9-tetrahydro-2H-acridin-10-yl]benzamide

InChIKey	`QRSMJZYCEJCRJJ-UHFFFAOYSA-N`
Compound Name	N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-4-[3,3,6,6-tetramethyl-1,8-dioxo-9-[4-[3,3,6,6-tetramethyl-1,8-dioxo-10-[4-[(5-sulfamoyl-1,3,4-thiadiazol-2-yl)carbamoyl]phenyl]-4,5,7,9-tetrahydro-2H-acridin-9-yl]phenyl]-4,5,7,9-tetrahydro-2H-acridin-10-yl]benzamide
Canonical SMILES	`CC1(C)CC(=O)C2=C(C1)N(c1ccc(C(=O)Nc3nnc(S(N)(=O)=O)s3)cc1)C1=C(C(=O)CC(C)(C)C1)C2c1ccc(C2C3=C(CC(C)(C)CC3=O)N(c3ccc(C(=O)Nc4nnc(S(N)(=O)=O)s4)cc3)C3=C2C(=O)CC(C)(C)C3)cc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Homologous
Avg pChEMBL	6.99
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P00918	CA2	Homo sapiens	Human	PF00194	7.8	Ki	ChEMBL;BindingDB
P43166	CA7	Homo sapiens	Human	PF00194	7.3	Ki	ChEMBL;BindingDB
P00915	CA1	Homo sapiens	Human	PF00194	6.5	Ki	ChEMBL;BindingDB
P22748	CA4	Homo sapiens	Human	PF00194	6.4	Ki	ChEMBL;BindingDB